Recent Updates — MDCXW

Medicus Pharma Ltd. completed a 1-for-50 share consolidation of its common shares, effective October 12, 2026. The board approved the ratio on September 24 after shareholder authorization at the June annual meeting. Every 50 pre-consolidation shares became one new share, with fractional amounts rounded down and paid in cash. Proportionate adjustments were applied to outstanding warrants, equity awards, and convertible securities. The company operates in the pharmaceutical industry.